Phase II study of docetaxel in combination with epirubicin and protracted venous infusion 5-fluorouracil (ETF) in patients with recurrent or metastatic breast cancer. A Yorkshire breast cancer research group study

Humphreys, AC, Dent, J, Rodwell, S et al. (5 more authors) (2004) Phase II study of docetaxel in combination with epirubicin and protracted venous infusion 5-fluorouracil (ETF) in patients with recurrent or metastatic breast cancer. A Yorkshire breast cancer research group study. British Journal of Cancer, 90 (11). pp. 2131-2134. ISSN 0007-0920

Abstract

Metadata

Authors/Creators:
Keywords: breast cancer; taxotere; epirubicin; infusional 5-fluorouracil
Dates:
  • Published: 1 June 2004
  • Accepted: 8 March 2004
  • Published (online): 11 May 2004
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Leeds Institute of Cancer and Pathology (LICAP) > Clinical Cancer Research (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 29 Aug 2019 12:08
Last Modified: 29 Aug 2019 12:08
Status: Published
Publisher: Springer Nature
Identification Number: https://doi.org/10.1038/sj.bjc.6601840

Share / Export

Statistics